Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalNo recent work listed

Jionghuang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-2618-6500; OpenAlex author ID A5063266614. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper

Papers 8

  1. Construction of a novel signature based on immune-related lncRNA to identify high and low risk pancreatic adenocarcinoma patients. First author DOI 10.1186/s12876-023-02916-y↗
  2. An Integrated Pan-Cancer Analysis of ADAMTS12 and Its Potential Implications in Pancreatic Adenocarcinoma. First author DOI 10.3389/fonc.2022.849717↗
  3. VRK2 activates TNFα/NF-κB signaling by phosphorylating IKKβ in pancreatic cancer. Co-author DOI 10.7150/ijbs.66313↗
  4. High Expression of P38α and Preoperative Carbohydrate Antigen 19-9 Indicate Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.21683↗
  5. Integrated Analysis of Long Non-Coding RNA and mRNA Expression Profile in Pancreatic Cancer Derived Exosomes Treated Dendritic Cells by Microarray Analysis. Co-author DOI 10.7150/jca.21749↗
  6. Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p. Co-author DOI 10.18632/oncotarget.4924↗
  7. Pancreatic cancer derived exosomes regulate the expression of TLR4 in dendritic cells via miR-203. First author DOI 10.1016/j.cellimm.2014.09.004↗
  8. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. Co-author DOI 10.1186/1477-7819-11-219↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liping Cao · 3 shared papers, 2018–2022 · strength 0.35
  2. Guoping Ding · 5 shared papers, 2013–2018 · strength 0.33
  3. Na Li · 1 shared paper, 2023 · strength 0.26
  4. Xiaoling Huang · 1 shared paper, 2023 · strength 0.26
  5. Guixing Jiang · 3 shared papers, 2015–2018 · strength 0.23
  6. Caiyun Song · 1 shared paper, 2022 · strength 0.22
  7. Dapeng Dong · 1 shared paper, 2022 · strength 0.22
  8. Liangjing Zhou · 3 shared papers, 2014–2018 · strength 0.18
  9. Shengnan Jia · 2 shared papers, 2018 · strength 0.18
  10. Kexiong Qiao · 1 shared paper, 2022 · strength 0.17
  11. Chaolei Zhang · 1 shared paper, 2022 · strength 0.17
  12. Liping Cao · 3 shared papers, 2013–2015 · strength 0.15
  13. Risheng Que · 1 shared paper, 2013 · strength 0.05
  14. Min Zhou · 1 shared paper, 2014 · strength 0.05
  15. Zhengrong Wu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.